THRSP mRNA levels in patients with advanced NAFLD fibrosis were significantly lower than in patients with mild NAFLD fibrosis (Figure 6D), reflecting fibrosis-related changes in D1 and D3 and worsened intrahepatic hypothyroidism with advancing fibrosis (Table 1). Here, THRSP is linked to metabolic dysfunction-associated steatotic liver disease.